Clin Adv Hematol Oncol
Dr. Amir Ali Faridi, MD
- Medicare services, 2024
- 155,688
- Medicare patients, 2024
- 972
- Part D claims, 2024
- 2,654
- Publications
- 1
- Clinical trials
- 4
- Practice address
- 5125 Texoma Medical Center Dr, Denison, TX 75020
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Texas Oncology Denison Cancer Center - HOPD
Acute Care Hospital outpatient department · Denison, Texas
Find Dr. Faridi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Amir Ali Faridi is a hematologist and oncologist in Denison, Texas
Dr. Faridi practices at Texas Oncology Denison Cancer Center - HOPD in Denison, Texas.
Dr. Faridi's NPI, 1659319028, was assigned on June 4, 2006. Dr. Faridi graduated from Dow University of Health Sciences in 1993. Dr. Faridi holds Texas license K4420.
- NPI
- 1659319028NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4981675063
- NPI enumeration date
- June 4, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 59
- Medical school graduation
- 1993
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Amir Ali Faridi practices at Texas Oncology Denison Cancer Center - HOPD in Denison, Texas
Dr. Faridi's primary practice is Texas Oncology Denison Cancer Center - HOPD, at 5125 Texoma Medical Center Dr, Denison, TX 75020.
- Texas Oncology Denison Cancer Center - HOPD5125 Texoma Medical Center Dr, Denison, TX 75020
Source: Dmand AI Affiliation Data
Dr. Amir Ali Faridi is affiliated with 4 sites of care and 1 medical group
Dr. Faridi's primary practice is Texas Oncology Denison Cancer Center - HOPD in Denison, Texas. Dr. Faridi is also affiliated with Texoma Medical Center. The medical group on file is Texas Oncology. Dmand AI also links Dr. Faridi to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Faridi's employer is on file too: a hospital.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Amir Ali Faridi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faridi practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Texas Oncology Denison Cancer Center - HOPD | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Amir Ali Faridi is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Faridi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Faridi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Faridi's licenses on file in 5 states: Texas, Oklahoma, Connecticut, Pennsylvania and Washington.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- Oklahoma license
- Connecticut license
- Pennsylvania license
- Washington license
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Faridi treats.
Hematologists and oncologists near Dr. Faridi
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Amir Ali Faridi billed Medicare for 155,688 services in 2024
CMS data shows 155,688 Medicare services from Dr. Faridi across 71 procedure codes in 2024, for 972 Medicare patients. Medicare paid $2,125,376 for them. Every service was in an office.
Dr. Faridi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 86,1612024: 104,26021%
- Other services
- 2023: 40,2062024: 40,128No change
- Lab and pathology
- 2023: 5,3042024: 5,4693%
- Tests and treatments
- 2023: 2,0922024: 2,1432%
- Surgery
- 2023: 1,7782024: 1,8977%
- Office and hospital visits
- 2023: 1,6112024: 1,5275%
- Imaging
- 2023: 2932024: 26410%
Dr. Faridi compared with the Texas median for hematologists and oncologists, 2024
- Dr. Faridi
- Texas median
- Medicare services
- 155,688vs 1,162134.0 times
- Medicare patients
- 972vs 2513.9 times
- Part D claims
- 2,384vs 4894.9 times
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Faridi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Faridi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Faridi and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Amir Ali Faridi treated 972 Medicare patients in 2024, average age 75
CMS counts 972 Medicare patients who saw Dr. Faridi in 2024. The largest group is 65 to 74, with 420 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Faridi's median patient age at 71, with 56% women.
Dr. Faridi's Medicare patients by age, 2024
Dr. Faridi's Medicare patients by sex, 2024
- Women55157%
- Men42143%
Chronic conditions among Dr. Faridi's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis53%
- Cancer47%
- Ischemic heart disease41%
- COPD37%
- Diabetes36%
- Anxiety29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Faridi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women56%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Amir Ali Faridi wrote 2,654 Medicare Part D claims in 2024
In 2024, Dr. Faridi wrote 2,654 Medicare Part D claims for 359 patients. 80% of them were for generic drugs. CMS names the drug for 2,384 of them, across 59 drugs with 11 or more claims each, at $4,275,960 in total drug cost. In 2023, CMS named 2,119 claims across 53 drugs.
Dr. Faridi's Part D claims by kind of drug, 2024
- Generic2,129 claims80%
- Brand-name525 claims20%
Dr. Faridi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Faridi's Part D claims, 2024
- Opioids14%362 of 2,654 claims
- Antibiotics3%68 of 2,654 claims
- Antipsychotics, patients 65 and over1%23 of 2,654 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,1192024: 2,38413%
Drugs named by CMS: 59 in 2024, 53 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Amir Ali Faridi scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Faridi for performance year 2024, reported through an alternative payment model (APM). Dr. Faridi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Faridi's MIPS scores, performance year 2024
- 85of 100Final score
- 67.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Amir Ali Faridi has 1 publication on record
Dmand AI links 1 paper to Dr. Faridi. Dr. Faridi's most frequent co-author is Ashraf R. Aziz, MD.
Dr. Faridi's most frequent co-authors
Recent publications by Dr. Faridi
See who Dr. Faridi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Faridi works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Amir Ali Faridi has worked on 4 clinical trials
Dmand AI links Dr. Faridi to 4 clinical trials. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Colonic Neoplasms.
Clinical trials with Dr. Faridi by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Faridi's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Colonic Neoplasms
- Gallbladder Neoplasms
- Gallbladder Diseases
Investigators on the most trials with Dr. Faridi
- Nihal Essa Abdulla, MD1 shared trial
- Spencer Henick Bachow, MD1 shared trial
- Rama Balaraman, MD1 shared trial
Recent clinical trials with Dr. Faridi
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (opens in a new tab)
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) (opens in a new tab)
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC (opens in a new tab)
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Amir Ali Faridi received $88,553 in industry payments from 2016 to 2025
CMS Open Payments shows 426 general payments to Dr. Faridi from 66 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $14,780.
General payments to Dr. Faridi by program year, 2016 to 2025
General payments to Dr. Faridi by kind, 2016 to 2025
- Consulting fees$55,81665%
- Food and beverage$8,1789%
- Travel and lodging$7,8199%
- Honoraria$6,9008%
- Other$7,6109%
Companies that paid Dr. Faridi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Amir Ali Faridi has 1 award and honors on record
Dmand AI lists 1 award for Dr. Faridi, most recently CMS Stage 1 2012 in 2012.
Awards and honors for Dr. Faridi
- 2012
- CMS Stage 1 2012
Source: Dmand AI Professional Profile Data
Dr. Amir Ali Faridi graduated from Dow University of Health Sciences
Dr. Faridi graduated from Dow University of Health Sciences in 1993.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Amir Ali Faridi accepts plans from 23 insurance carriers
Dr. Faridi is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Cigna
- Elevance
- HCSC
- Humana
- Alliant Health Plans
- +15 more carriersWith a free account
Plan types Dr. Faridi accepts, by number of carriers
- PPO14
- HMO13
- Medicare9
- POS5
- EPO4
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Amir Ali Faridi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Amir Ali Faridi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Amir Ali Faridi's NPI number?
Dr. Amir Ali Faridi's NPI number is 1659319028. It was assigned on June 4, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Amir Ali Faridi?
Dr. Amir Ali Faridi is a hematologist and oncologist in Denison, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Amir Ali Faridi practice?
Dr. Faridi practices at 5125 Texoma Medical Center Dr, Denison, TX 75020. Dr. Faridi's primary practice is Texas Oncology Denison Cancer Center - HOPD in Denison, Texas. Dmand AI also links Dr. Faridi to 1 hospital and 1 group practice or clinic.
What is Dr. Amir Ali Faridi's medical license number?
Dr. Faridi holds Texas license K4420, one of the licenses on file in 5 states.
Which states has Dr. Amir Ali Faridi been licensed in?
Dmand AI has state licenses on file for Dr. Faridi in Texas (1998 to 2026), Oklahoma (2017 to 2026), Connecticut (1997 to 1998), Pennsylvania (1998) and Washington (1995 to 1996).
Which hospitals is Dr. Amir Ali Faridi affiliated with?
Dr. Faridi is affiliated with Texoma Medical Center. Dmand AI links Dr. Faridi to 1 more hospital.
What medical group is Dr. Amir Ali Faridi part of?
Dr. Faridi is linked to Texas Oncology.
Does Dr. Amir Ali Faridi accept Medicare?
Yes. CMS data shows Dr. Faridi billed Medicare for 155,688 services in 2024, and Dr. Faridi accepts Medicare assignment.
What is Dr. Amir Ali Faridi's MIPS score?
Dr. Faridi's MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Amir Ali Faridi see?
CMS counts 972 Medicare patients who saw Dr. Faridi in 2024, with an average age of 75.
Show 9 more questionsShow fewer questions
Is Dr. Amir Ali Faridi board certified?
Yes. Dr. Faridi is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Amir Ali Faridi bill to Medicare?
In 2024, Dr. Faridi's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J9271) and injected or infused drug (J1756).
Where did Dr. Amir Ali Faridi go to medical school?
Dr. Faridi graduated from Dow University of Health Sciences in 1993.
What drugs does Dr. Amir Ali Faridi prescribe most?
In 2024 Medicare Part D data, Dr. Faridi's most prescribed drugs by claims were Anastrozole, Hydrocodone-Acetaminophen and Prochlorperazine Maleate.
Has Dr. Amir Ali Faridi received payments from drug or device companies?
CMS Open Payments shows $88,553 in general payments to Dr. Faridi from 66 companies from 2016 to 2025. The largest total came from Bayer HealthCare Pharmaceuticals Inc.
How long has Dr. Amir Ali Faridi been practicing?
Dr. Faridi graduated from medical school in 1993, 33 years ago.
Does Dr. Amir Ali Faridi do research?
Dmand AI links 1 publication to Dr. Faridi. Dr. Faridi has worked on 4 clinical trials.
Who does Dr. Amir Ali Faridi publish with?
Dr. Faridi's most frequent co-authors are Ashraf R. Aziz, MD (1 shared paper).
What insurance does Dr. Amir Ali Faridi accept?
Dr. Faridi is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card